Global Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User- Global Forecast to 2026
Neurodiagnostics Market is valued at 6.02 USD Billion in 2019 and expected to reach USD 9.95 Billion by 2026 with the CAGR of 7.4% over the forecast period.
Scope of the report
This report analyses the global market for Neurodiagnostics. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Hitachi Medical Corporation, Nihon Kohden Corporation, Fonar Corporation, Neusoft Medical Systems Co., Ltd. NeuroNexus Technologies, Inc., Lifelines Neurodiagnostic Systems, Inc and others
Above mentioned companies were scrutinized to assess competitive landscape of global Neurodiagnostics market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Neurodiagnostics market report provides insights on new trade regulations, industry value chain analysis, market size, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Product
o Diagnostic Systems
o Clinical Testing Instruments
o Reagents & Consumables
• Condition
o Neuro Degenerative Diseases
o Epilepsy
o Stroke
o Sleep Disorders
o Other
• End-User
o Hospitals and Surgery Centers
o Neurology Centers
o Ambulatory Care Centers
o Diagnostic Laboratories
o Research Laboratories & Academic Institutes
Report Coverage
• An overview of the global Neurodiagnostics market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Neurodiagnostics market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Neurodiagnostics market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Neurodiagnostics Market Report
• What is the impact of COVID 19 epidemic on the global Neurodiagnostics market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Neurodiagnostics market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Neurodiagnostics market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?
Table of Contents
1. Introduction
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
3.1. Market Definition
3.2. Market Scope
3.3. Market Drivers
3.4. Market Restraints
3.5. Market Opportunities and Trends
3.6. Porter’s five force analysis
3.7. SWOT Analysis
3.8. PEST Analysis
3.9. Patent Analysis
3.10. Impact of COVID 19 on Global Neurodiagnostics Market
4. Neurodiagnostics Market, By Product, Market Size and Forecast 2016 -2026 (USD Million)
4.1. Global Neurodiagnostics Market By Product, 2016 -2026 (USD Million)
4.1.1. Global Neurodiagnostics Market By Diagnostic Systems
4.1.2. Global Neurodiagnostics Market By Clinical Testing Instruments
4.1.3. Global Neurodiagnostics Market By Reagents & Consumables
4.2. Global Neurodiagnostics Market By Product Share, 2016 -2026 (%)
5. Neurodiagnostics Market, By Condition, Market Size and Forecast 2016 -2026 (USD Million)
5.1. Global Neurodiagnostics Market By Condition,2016 -2026 (USD Million)
5.1.1. Global Neurodiagnostics Market By Neuro Degenerative Diseases
5.1.2. Global Neurodiagnostics Market By Epilepsy
5.1.3. Global Neurodiagnostics Market By Stroke
5.1.4. Global Neurodiagnostics Market By Sleep Disorders
5.2. Global Neurodiagnostics Market By Other Global Neurodiagnostics Market By Condition Share, 2016 -2026 (%)
6. Neurodiagnostics Market, By End User, Market Size and Forecast 2016 -2026 (USD Million)
6.1. Global Neurodiagnostics Market By End User, 2016 -2026 (USD Million)
6.1.1. Global Neurodiagnostics Market By Hospitals and Surgery Centers
6.1.2. Global Neurodiagnostics Market By Neurology Centers
6.1.3. Global Neurodiagnostics Market By Ambulatory Care Centers
6.1.4. Global Neurodiagnostics Market By Diagnostic Laboratories
6.1.5. Global Neurodiagnostics Market By Research Laboratories & Academic Institutes
6.2. Global Neurodiagnostics Market By End User Share, 2016 -2026 (%)
7. Neurodiagnostics Market, By Region Market Size and Forecast 2016 -2026
7.1. NORTH AMERICA
7.1.1. Key Findings
7.1.2. Impact of COVID 19
7.1.3. Key market trends, growth factors and opportunities
7.1.4. North America Neurodiagnostics Market by Country 2016 -2026 (USD Million)
7.1.5. North America Neurodiagnostics Market By Product2016 -2026 (USD Million)
7.1.6. North America Neurodiagnostics Market By Condition 2016 -2026 (USD Million)
7.1.7. North America Neurodiagnostics Market By End User 2016 -2026 (USD Million)
7.2. EUROPE
7.2.1. Key Findings
7.2.2. Impact of COVID 19
7.2.3. Key market trends, growth factors and opportunities
7.2.4. Europe Neurodiagnostics Market by Country 2016 -2026 (USD Million)
7.2.5. Europe Neurodiagnostics Market By Product 2016 -2026 (USD Million)
7.2.6. Europe Neurodiagnostics Market By Condition 2016 -2026 (USD Million)
7.2.7. Europe Neurodiagnostics Market By End User 2016 -2026 (USD Million)
7.3. ASIA PACIFIC
7.3.1. Key Findings
7.3.2. Impact of COVID 19
7.3.3. Key market trends, growth factors and opportunities
7.3.4. Asia Pacific Neurodiagnostics Market by Country 2016 -2026 (USD Million)
7.3.5. Asia Pacific Neurodiagnostics Market By Product 2016 -2026 (USD Million)
7.3.6. Asia Pacific Neurodiagnostics Market By Condition 2016 -2026 (USD Million)
7.3.7. Asia Pacific Neurodiagnostics Market By End User 2016 -2026 (USD Million)
7.4. LATIN AMERICA
7.4.1. Key Findings
7.4.2. Impact of COVID 19
7.4.3. Key market trends, growth factors and opportunities
7.4.4. Latin America Neurodiagnostics Market by Country 2016 -2026 (USD Million)
7.4.5. Latin America Neurodiagnostics Market By Product 2016 -2026 (USD Million)
7.4.6. Latin America Neurodiagnostics Market By Condition 2016 -2026 (USD Million)
7.4.7. Latin America Neurodiagnostics Market By End User 2016 -2026 (USD Million)
7.5. MIDDLE EAST AND AFRICA
7.5.1. Key Findings
7.5.2. Impact of COVID 19
7.5.3. Key market trends, growth factors and opportunities
7.5.4. Middle East and Africa Neurodiagnostics Market by Country 2016 -2026 (USD Million)
7.5.5. Middle East and Africa Neurodiagnostics Market By Product 2016 -2026 (USD Million)
7.5.6. Middle East and Africa Neurodiagnostics Market By Condition 2016 -2026 (USD Million)
7.5.7. Middle East and Africa Neurodiagnostics Market By End User 2016 -2026 (USD Million)
8. Competitive Landscape Analysis
8.1. Global Neurodiagnostics Market Company Revenue, (USD Million), 2016-2019
8.2. Global Neurodiagnostics Market Company Share, (%), 2016-2019
9. Company Profiles
9.1. GE Healthcare
9.2. Siemens Healthineers
9.3. Philips Healthcare
9.4. Canon Medical Systems Corporation
9.5. Hitachi Medical Corporation
9.6. Nihon Kohden Corporation
9.7. Fonar Corporation
9.8. Neusoft Medical Systems Co., Ltd
9.9. NeuroNexus Technologies, Inc.
9.10. Lifelines Neurodiagnostic Systems, Inc
9.11. Others
10. Appendix
11. List of Tables
12. List of Figures
